Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Response to comment on: Intraocular Lens Power Calculation - Comparing Big Data Approaches to Established Formulas

2 months 3 weeks ago
No abstract
Liam D Redden

Characterization of astaxanthin isomers in different types of salmon filets and human plasma after salmon consumption

2 months 3 weeks ago
Astaxanthin, a marine carotenoid with antioxidant and anti-inflammatory properties, exists in various isomers in salmon. Despite salmon being a key dietary source of astaxanthin in American diets, the isomer contents across salmon types, processing methods, and human plasma post-consumption remains underexplored. Using mass spectrometry, we analyzed astaxanthin isomers, EPA, and DHA in wild and farmed salmon, processed salmon products, and human plasma following a feeding study. Results showed...
Peiran Lu

G2211 Coding Guidance in Urogynecology

2 months 3 weeks ago
No abstract
Mamta M Mamik

Vitamin D Deficiency and Cardiovascular Disease Risk Factors Among American Indian Adolescents: The Strong Heart Family Study

2 months 3 weeks ago
CONCLUSION: Vitamin D deficiency in adolescence may be associated with the CVD risk factors obesity, low HDL-C, and metabolic syndrome and may also contribute to the development of diabetes later in life.
Jessica A Reese

Bleeding Complications, Transfusion, and Acute Care Costs After Major Arthroplasty in Patients With Hereditary Bleeding Disorders: A National Healthcare Database Analysis

2 months 3 weeks ago
CONCLUSIONS: THA and TKA in patients with hereditary BDs are relatively safe, with most outcomes comparable to controls. However, higher rates of bleeding, transfusion, and VTE underscore the need for optimizing anemia management and targeted use of CFCs along with antifibrinolytic therapy.
Kenneth E Stewart

Pagination

  • Previous page ‹ Previous
  • Page 46
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2025. All rights reserved. Designed By Zymphonies